ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Surgical Oncology

Study Finds Correlations Between Certain Factors, Rates of Nodal Upstaging

Haleigh Behrman
on: February 25, 2025In: Meeting News, Risk Assessment and Reduction, Surgical Oncology
Study Finds Correlations Between Certain Factors, Rates of Nodal Upstaging

Dr. Stella Martinez recently shared the latest data and explored the challenges and opportunities in lung cancer surgery in Latin America. Read more


Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data

Erin Jungmeyer
on: March 12, 2024In: Meeting News, Surgical Oncology
Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data

Surgeon Erin Gillaspie, MD, said surgery still has a role in the treatment of mesothelioma while medical oncologist Hedy Kindler, MD, said newer systemic therapies make surgery obsolete in this space. Read more

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

Sara Ghandehari, MD, FACHE
+more
on: February 27, 2024In: Evolving Standards of Care, Surgical Oncology
Recurrence Remains a Risk Even for Patients Diagnosed via Screening

Drs. Sara Ghandehari and Weijia Chua discuss how to best monitor patients when guidelines and protocols vary and more research is needed. Read more

ELCC Session Offers Surgical Perspective in Context of Neoadjuvant Immunotherapy

Erin Jungmeyer
on: May 24, 2023In: Meeting News, Radiation Oncology, Surgical Oncology
ELCC Session Offers Surgical Perspective in Context of Neoadjuvant Immunotherapy

Presenter Dr. Alex Brunelli says neoadjuvant chemoimmunotherapy is a promising and well-tolerated treatment option in select patients with stage III NSCLC. Read more

Radiation Oncologist Makes Case for Radiotherapy for Local Treatment of Select Patients

Erin Jungmeyer
on: May 24, 2023In: Meeting News, Surgical Oncology
Radiation Oncologist Makes Case for Radiotherapy for Local Treatment of Select Patients

Can radiotherapy replace surgery in stage III NSCLC in the era of immunotherapy? During ELCC 23, Dr. Sara Ramella turned to the data to answer that question. Read more

Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?

Osa Ogbeide, MD
+more
on: December 06, 2022In: Evolving Standards of Care, Surgical Oncology
Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?

In a “tale of two trials,” Drs. Ogbeide and Osarogiagbon use insights from the ALCHEMIST trial population to try to understand outcomes disparities between North America and Japan. Read more

Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study

Cecilia Pompili, MD PhD
+more
on: April 26, 2022In: Radiation Oncology, Surgical Oncology
Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study

SABR patients were stable during the 12 months while surgical patients reported clinically significant deterioration at 6 weeks. Read more

Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer

Joe Y. Chang, MD, PhD
+more
on: March 09, 2022In: Radiation Oncology, Surgical Oncology
Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer

Practical aspects of clinically managing operable SABR patients are important for the long-term care of this unique population. Read more

Bronchoscopic Ablation: A Small Step for Heat Therapy, a Giant Leap for Lung Cancer

Janani S. Reisenauer
+more
on: September 17, 2021In: Surgical Oncology
Bronchoscopic Ablation: A Small Step for Heat Therapy, a Giant Leap for Lung Cancer

Surgery has long been the gold standard for diagnosis and management of early-stage operable lung cancer. For patients with inoperable disease or more extensive disease, however, alternative approaches are emerging. […] Read more

Transbronchial Microwave Ablation of Malignant Lung Nodules: Outcomes, Challenges, and Perspective

Joyce W.Y. Chan
+more
on: August 13, 2021In: Surgical Oncology
Transbronchial Microwave Ablation of Malignant Lung Nodules: Outcomes, Challenges, and Perspective

With increasing availability of CT scans and strong evidence for the utility of low-dose CT screening in high-risk populations,1 an increasing number of small lung nodules are being incidentally discovered. […] Read more

12

SEARCH ILCN

Archives

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy